Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Moss

Showing results (191-200 of 307) with videos related to

Pageof 31
Sort By:
Biorxiv : the Preprint Server for Biology|January 14, 2021
MVA Vector Vaccines Inhibit SARS CoV-2 Replication in Upper and Lower Respiratory Tracts of Transgenic Mice and Prevent Lethal DiseaseRuikang Liu, Jeffrey L Americo, Catherine A Cotter, et al.
Vaccine|March 16, 2007
Dose-response studies for the elicitation of CD8 T cells by a DNA vaccine, used alone or as the prime for a modified vaccinia Ankara boostJinyan Liu, Michael Hellerstein, Michael McDonnel, et al.
Nucleic Acids Research|May 17, 2013
A concept of eliminating nonhomologous recombination for scalable and safe AAV vector generation for human gene therapyBiao Dong, Andrea R Moore, Jihong Dai, et al.
Virology|March 11, 2014
Elimination of A-type inclusion formation enhances cowpox virus replication in mice: implications for orthopoxvirus evolutionRobin J Kastenmayer, Liliana Maruri-Avidal, Jeffrey L Americo, et al.
Virology Journal|February 16, 2005
Simian immunodeficiency virus (SIV) envelope quasispecies transmission and evolution in infant rhesus macaques after oral challenge with uncloned SIVmac251: increased diversity is associated with neutralizing antibodies and improved survival in previously immunized animalsJennifer L Greenier, Koen K A Van Rompay, David Montefiori, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2021
One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infectionRuikang Liu, Jeffrey L Americo, Catherine A Cotter, et al.
Journal of Virology|May 8, 2009
Elucidating and minimizing the loss by recombinant vaccinia virus of human immunodeficiency virus gene expression resulting from spontaneous mutations and positive selectionLinda S Wyatt, Patricia L Earl, Wei Xiao, et al.
The Journal of Experimental Medicine|October 24, 2007
Adjuvanting a DNA vaccine with a TLR9 ligand plus Flt3 ligand results in enhanced cellular immunity against the simian immunodeficiency virusMarcin Kwissa, Rama R Amara, Harriet L Robinson, et al.
Plos Pathogens|May 31, 2019
SPI-1 is a missing host-range factor required for replication of the attenuated modified vaccinia Ankara (MVA) vaccine vector in human cellsRuikang Liu, Jorge D Mendez-Rios, Chen Peng, et al.
Plos One|May 5, 2012
Genome sequence of erythromelalgia-related poxvirus identifies it as an ectromelia virus strainJorge D Mendez-Rios, Craig A Martens, Daniel P Bruno, et al.
Pageof 31

Showing results (191-200 of 307) with videos related to

Sort By:
Pageof 31
Biorxiv : the Preprint Server for Biology|January 14, 2021
MVA Vector Vaccines Inhibit SARS CoV-2 Replication in Upper and Lower Respiratory Tracts of Transgenic Mice and Prevent Lethal DiseaseRuikang Liu, Jeffrey L Americo, Catherine A Cotter, et al.
Vaccine|March 16, 2007
Dose-response studies for the elicitation of CD8 T cells by a DNA vaccine, used alone or as the prime for a modified vaccinia Ankara boostJinyan Liu, Michael Hellerstein, Michael McDonnel, et al.
Nucleic Acids Research|May 17, 2013
A concept of eliminating nonhomologous recombination for scalable and safe AAV vector generation for human gene therapyBiao Dong, Andrea R Moore, Jihong Dai, et al.
Virology|March 11, 2014
Elimination of A-type inclusion formation enhances cowpox virus replication in mice: implications for orthopoxvirus evolutionRobin J Kastenmayer, Liliana Maruri-Avidal, Jeffrey L Americo, et al.
Virology Journal|February 16, 2005
Simian immunodeficiency virus (SIV) envelope quasispecies transmission and evolution in infant rhesus macaques after oral challenge with uncloned SIVmac251: increased diversity is associated with neutralizing antibodies and improved survival in previously immunized animalsJennifer L Greenier, Koen K A Van Rompay, David Montefiori, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 10, 2021
One or two injections of MVA-vectored vaccine shields hACE2 transgenic mice from SARS-CoV-2 upper and lower respiratory tract infectionRuikang Liu, Jeffrey L Americo, Catherine A Cotter, et al.
Journal of Virology|May 8, 2009
Elucidating and minimizing the loss by recombinant vaccinia virus of human immunodeficiency virus gene expression resulting from spontaneous mutations and positive selectionLinda S Wyatt, Patricia L Earl, Wei Xiao, et al.
The Journal of Experimental Medicine|October 24, 2007
Adjuvanting a DNA vaccine with a TLR9 ligand plus Flt3 ligand results in enhanced cellular immunity against the simian immunodeficiency virusMarcin Kwissa, Rama R Amara, Harriet L Robinson, et al.
Plos Pathogens|May 31, 2019
SPI-1 is a missing host-range factor required for replication of the attenuated modified vaccinia Ankara (MVA) vaccine vector in human cellsRuikang Liu, Jorge D Mendez-Rios, Chen Peng, et al.
Plos One|May 5, 2012
Genome sequence of erythromelalgia-related poxvirus identifies it as an ectromelia virus strainJorge D Mendez-Rios, Craig A Martens, Daniel P Bruno, et al.
Pageof 31